Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Aliment Pharmacol Ther. 2024 May;59(10):1294-1295. doi: 10.1111/apt.17992.
NO ABSTRACT
PMID:38652769 | DOI:10.1111/apt.17992
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Editorial: Crystalising the burden of steatotic liver disease-Authors’ reply
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease Psychedelics in treatment of postraumatic stress disorder Review article: Hepatic steatosis and its associations with acute and chronic liver diseases Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies MDMA-assisted therapy for PTSD Modeling resilience to sleep disruption to study resistance to Alzheimer's disease Associations of dietary sugars with liver stiffness in Latino adolescents with obesity differ on PNPLA3 and liver disease severity Reply to: Frailty and ethics at the end of life: The importance of a comprehensive assessment A novel dual near-infrared fluorescent probe for bioimaging and visualization of viscosity in acute alcoholic liver injury Editorial Perspective: Extending IPDMA methodology to drive treatment personalisation in child mental health Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depression Epidemiology, screening, and Co-management of type 2 diabetes mellitus and Metabolic-dysfunction associated steatotic liver disease Reply to: "From NAFLD to MASLD: Promise and pitfalls of a new definition": EASL, AASLD and ALEH stand united to advance the field of steatotic liver disease Metabolic-Associated Steatotic Liver Disease (MASLD): A New Term for a More Appropriate Therapy in Pediatrics? Editorial: "What say you?" The promise and potential pitfalls of using automated and passive monitoring approaches to assess parenting behaviours from verbal and written communication Editorial: "What say you?" The promise and potential pitfalls of using automated and passive monitoring approaches to assess parenting behaviours from verbal and written communication Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of… New nomenclature for fatty liver disease Erythropoietin hyporesponsiveness in non-alcoholic fatty liver disease The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives Editorial perspective: Transforming child and adolescent mental health services and systems (CAMHSS) around the globe - the importance of diversity, inclusion and equity in CAMHSS research Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease The Transition in Terminology: From Non-alcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) to Metabolic-associated Steatotic Liver Disease (MASLD) Para-fluorofentanyl: Coincidence or intentional? Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: A systematic review Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: A systematic review Obituary: Kypros Kypri Ethical concerns related to the use of artificial intelligence in dermatopathology E-cigarette policies in Aotearoa (New Zealand): An Indigenous perspective Spatial genomics: mapping human steatotic liver disease Harnessing AI as an enabler for access to mental health care services Harnessing AI as an enabler for access to mental health care services Measuring the exposome in bipolar disorder Addiction Lives: Maggie Brady Enhancing nurse retention: Insights from "SHOULD I STAY OR SHOULD I GO" Stakeholders cannot simply wait for the gambling evidence-base to develop: We must all help to build it Artificial intelligence is poised to usher in a paradigm shift in surgery: comment Physiology is all about interactions: The prolactin and growth hormone systems as exemplars The emergence of nitazenes on the Irish heroin market and national preparation for possible future outbreaks In memoriam: Roger Guillemin, neuroendocrinologist, Nobel Prize in physiology or medicine Contingency management as a maintenance intervention in the long-term treatment of substance use disorders Why does problem gambling in psychotic disorders pose such a challenge for comprehension? Mitigating firearm risks in older adults with delirium through preventive measures The relationship between alcohol use disorder and suicide by means: Context dependent Mitigating firearm risks in older adults with delirium through preventive measures Risk factors of delirium after gastrointestinal surgery: A meta-analysis How far have we advanced in early intervention for bipolar disorder? The time has come to question the infinite maintenance treatment for bipolar disorders ADHD medications for cognitive impairment in bipolar disorders Commentary on Carrasquilla et al.: Smoking and obesity; uncovering causal mechanisms through triangulation of different methods Beyond the microscope: Unveiling bacterial vaginosis with AI-powered multiomics data analysis Cognitive outcomes of children and adults with sickle cell anaemia: A contemporary cohort Introduction to Progress and Puzzles of Cognitive Science: Introduction to a Wiley Virtual Issue Letter to the Editor concerning "Electroconvulsive therapy in the maintenance phase of psychotic unipolar depression" Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease: A cross-sectional study of NHANES 2017-2018 Artificial dermatitis versus artificial intelligence: Detecting etiology with Google Lens Navigating the digital age: The need for online-specific gambling marketing regulations Navigating the digital age: The need for online-specific gambling marketing regulations Enhancing remote nursing education in Taiwan: Lessons from the COVID-19 pandemic and future directions Community testing practices prompt the rethinking of gold standard autism assessment
Evidence Blueprint
Editorial: Crystalising the burden of steatotic liver disease-Authors’ reply
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Editorial: Crystalising the burden of steatotic liver disease-Authors’ reply
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease Psychedelics in treatment of postraumatic stress disorder Prevalence of at-risk MASH, MetALD and alcohol-associated steatotic liver disease in the general population Review article: Hepatic steatosis and its associations with acute and chronic liver diseases The silent burden of non-alcoholic fatty liver disease in the elderly: A global burden of disease analysis Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies Review article: Current indications and selection criteria for early liver transplantation in severe alcohol-associated hepatitis Meta-analysis: Impact of intragastric balloon therapy on NAFLD-related parameters in patients with obesity The rs72613567:TA polymorphism in HSD17B13 is associated with survival benefit after development of hepatocellular carcinoma Meta-analysis: Efficacy and safety of fibroblast growth factor 21 analogues for the treatment of non-alcoholic steatohepatitis and non-alcoholic steatohepatitis-related fibrosis Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction-associated steatotic liver disease - The Gut and Obesity in Asia (GO-ASIA) Study Systematic review: Glycomics as diagnostic markers for hepatocellular carcinoma Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis MAFLD fibrosis score: Using routine measures to identify advanced fibrosis in metabolic-associated fatty liver disease First in human randomised trial of J2H-1702: A novel 11β-hydroxysteroid dehydrogenase type 1 inhibitor for non-alcoholic steatohepatitis treatment MDMA-assisted therapy for PTSD Modeling resilience to sleep disruption to study resistance to Alzheimer's disease Commentary: The evidence base regarding the long-term effects of childhood mental disorder treatments needs to be strengthened - reply to Dekkers et al. (2023) Associations of dietary sugars with liver stiffness in Latino adolescents with obesity differ on PNPLA3 and liver disease severity Reply to: Comment on: Association of sulfonylureas with the risk of dementia: A population-based cohort study Reply to: Frailty and ethics at the end of life: The importance of a comprehensive assessment Potential Mechanisms Involving in the Pathogenesis of MASLD and Targets for Pharmacotherapy. Advancements in Metabolic Associated Steatotic Liver Disease (MASLD) Research: Diagnostics, Small Molecule Developments and Future Directions Letter regarding 'Association of thyroid function with non-alcoholic fatty liver disease in recent-onset diabetes' Reply to Ng: a closer look at late-onset psychoses for the general internist The promise of N-acetylcysteine in the treatment of obsessive-compulsive disorder Reply to: Positive aspects of caregiving attenuate the relationship between behavioral bother and anxiety and depressive symptoms in dementia family caregivers. Geriatr. Gerontol. Int. 2023;1. https://doi.org/10.1111/ggi.1460 Reply to: Disease latency and new-user versus prevalent-user cohort designs: Implications for pharmacoepidemiology in dementia Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification A novel dual near-infrared fluorescent probe for bioimaging and visualization of viscosity in acute alcoholic liver injury Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China Relationship of ferritin and hepcidin with disease severity in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus Editorial: Prevention is the best cure - or is it? A cautionary tale MBOAT7 in liver and extrahepatic diseases Editorial Perspective: Extending IPDMA methodology to drive treatment personalisation in child mental health Correction to "Hepatobiliary and Pancreatic: Challenges in the diagnosis of hepatic nodules in patients with alcoholic liver cirrhosis" Steatotic liver disease is the most important somatic determinant of quality of life in patients with obesity: A cross-sectional study Exclusive liquor and cocktail consumption is associated with at-risk fibrosis among nonheavy alcohol users with metabolic dysfunction-associated steatotic liver disease The double roles of T cell-mediated immune response in the progression of MASLD Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype Commentary on Booth et al.: Measuring the health burden of homelessness Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depression Liver disease mortality and hospitalisations among people with type 2 diabetes mellitus: A population-based study Obituary: Travis Thompson-Editorial Epidemiology, screening, and Co-management of type 2 diabetes mellitus and Metabolic-dysfunction associated steatotic liver disease Non-alcoholic fatty liver disease, women's health and the role of the environment Reply to: "From NAFLD to MASLD: Promise and pitfalls of a new definition": EASL, AASLD and ALEH stand united to advance the field of steatotic liver disease Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: An updated meta-analysis Metabolic-Associated Steatotic Liver Disease (MASLD): A New Term for a More Appropriate Therapy in Pediatrics? Editorial: "What say you?" The promise and potential pitfalls of using automated and passive monitoring approaches to assess parenting behaviours from verbal and written communication Editorial: "What say you?" The promise and potential pitfalls of using automated and passive monitoring approaches to assess parenting behaviours from verbal and written communication Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of… Editorial: Generative artificial intelligence and the ecology of human development From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus New nomenclature for fatty liver disease Liver fat as risk factor of hepatic and cardiometabolic diseases Erythropoietin hyporesponsiveness in non-alcoholic fatty liver disease Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study Therapeutic management of metabolic dysfunction associated steatotic liver disease The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes Exercise training improves serum biomarkers of liver fibroinflammation in patients with metabolic dysfunction-associated steatohepatitis